menu
The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030.
The report features an extensive study on the contract service providers offering drug product manufacturing services within the biopharmaceutical industry.

 

A steadily growing demand for biologic fill / finishservices has generated a range of new opportunities for contract serviceproviders; stakeholders have invested heavily to ensure product integrity andsafety

 

Roots Analysis is pleased to announce the publication of its recent study,titled, “Biologics Fill /Finish Services Market, 2019-2030.

 

The report features an extensive study on the contractservice providers offering drug product manufacturing services within thebiopharmaceutical industry. The study features in-depth analysis, highlightingthe capabilities of a diverse set of companies that claim to specialize in fill/ finish operations. Amongst other elements, the report includes:

§ A detailed review of the overall landscape of contract fill/ finish services market for biopharmaceuticals. 

§ A region-wise, company competitiveness analysis,highlighting prominent fill / finish service providers across various packagingtypes.

§ Elaborate profiles of key players across key geographies(North America, Europe and Asia-Pacific).

§ An analysis of the recent collaborations (signed since2013) focused on the contract fill / finish services for biologics.

§ A detailed analysis of the expansions undertaken (since2013) by various service providers for augmenting their respective fill /finish service portfolios.

§ An estimate of the global contract fill / finish capacity,by taking into consideration the capacities of various fill / finish serviceproviders.

§ An informed estimate of the annual demand for fill / finishof biologics, taking into account the top 20 biologics.

§ An analysis to identify the key performance indicators forservice providers active in the domain.

§ A case study to highlight the benefits of using robotic /automated equipment for aseptic fill / finish processes.

§ A case study to highlight the role of ready-to-usepackaging containers in aseptic fill / finish operations.

§ A discussion on the potential growth areas and recent trendsimpacting the outsourcing potential for biopharmaceuticals.

§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)

 

To request for sample report - https://www.rootsanalysis.com/reports/256/request-sample.html

 

§  Types of Primary Packaging Containers

§  Ampoules

§  Cartridges

§  Syringes

§  Vials

§  Types of Biologics

§  Peptides / proteins

§  Antibodies

§  Vaccines

§  Cell therapies

§  Gene therapies

§  Viral products

§  Oligonucleotides

§  Others

 

§  Company Size

§  Small-sized

§  Mid-sized

§  Large / very large

 

§  Scale of Operation

§  Preclinical

§  Clinical

§  Commercial

 

§  Key Therapeutic Areas

§  Cancer

§  Infectious diseases

§  Autoimmune diseases

§  Cardiovascular diseases

§  Other indications

 

§  Key Geographical Regions

§  North America (US, Canada)

§  Europe (UK, France, Germany, Italy, Spain andrest of the Europe)

§  Asia-Pacific (Japan, China, South Korea, Indiaand Australia)

 

The report featuresinputs from a number of eminent industry stakeholders, according to whom,“Currently, majority of biologics are being filled in vials, however, thescenario is likely to change in the future due to the growing demand andpreference for self-administration devices.” The report features detailedtranscripts of discussions held with the following experts:

§ Ales Sima, Business Development Manager,oncomed manufacturing 

§ Gregor Kawaletz, Chief Commercial Officer,IDT Biologika

§ Jos Vergeest, International BusinessDeveloper, HALIX

§ Purushottam Singnurkar, Research Directorand Head of Formulation Development, Syngene International

 

Keycompanies covered in the report

§  Advanced BioScience Laboratories (ABL)

§  Albany Molecular Research (AMRI)

§  Biocon

§  BioPharma Solutions

§  BioReliance

§  Boehringer Ingelheim BioXcellence

§  ChemPartner

§  Emergent BioSolutions

§  IDT Biologika

§  Lonza

§  LuinaBio

§  Mycenax Biotech

§  Patheon

§  Recipharm

§  Vetter Pharma

§  WuXi Biologics

 

Formore information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/biologics-fill--finish-services-market-2019-2030/256.html

 

Other Recent Offerings

1.    Vaccine Contract Manufacturing Market (2ndEdition), 2019-2030

2.    Medical Device Contract Manufacturing Market,2019-2030

3.    Elastomeric Closure Components Market ForVials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields,Plungers, Stoppers, Seals, Tip Caps and Other Closures

4.    Biopharma Contract Manufacturing Market (3rdEdition), 2019 - 2030

5.    Patient Recruitment and Retention ServicesMarket, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com

 

Contact Information

RootsAnalysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis